
GC70857
LIMK-IN-1
Also known as (2S)-N'-(3-bromophenyl)-N-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide
LIMK-IN-1 (Compound 14) is an inhibitor of LIM-Kinase (LIMK), with IC50s of 0·5 nM and 0·9 nM for LIMK1 and LIMK2, respectively
ChemicalCAS1116571-01-7MW453.34FormulaC20H21BrN8
- CAS number
- 1116571-01-7
- Molecular weight
- 453.34
- Formula
- C20H21BrN8
- Solubility
- DMSO : 125 mg/mL (275·73 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- KSECQYDNQYAZMQ-AWEZNQCLSA-N
- Catalogue number
- GC70857
- Brand
- GLPBIO
Computed properties PubChem CID 44477445 · XLogP 3.6 · TPSA 96.2 Ų · H-bond donors 2
- XLogP
- 3.6
- TPSA
- 96.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 29
SMILES C[C@H]1CN(CCN1C(=NC2=CC(=CC=C2)Br)NC#N)C3=NC=NC4=C3C(=CN4)C
Computed descriptors from PubChem (CID 44477445), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il